Thomas, Mike
Article History
Received: 10 September 2014
Revised: 16 December 2014
Accepted: 19 December 2014
First Online: 5 March 2015
Competing interests
: Neither MT nor any member of his close family has any shares in pharmaceutical companies. In the past 3 years, he has received the speaker’s honoraria for speaking at sponsored meetings or satellite symposia at conferences from the following companies marketing respiratory and allergy products: Aerocrine, Astra Zeneca, Boehringer Inglehiem, GSK, MSD, Novartis and Teva. MT is the former chief medical adviser to the charity Asthma UK, a member of the BTS SIGN Asthma guideline group and the NICE Asthma guideline group. MT is an Associate Editor of <i>npj Primary Care Respiratory Medicine</i>, but was not involved in the editorial review of, nor the decision to publish, this article.